Metastatic appendiceal cancer treated with Yttrium 90 radioembolization and systemic chemotherapy: A case report

Figure 7 A restaging skull base to mid-thigh fluorodeoxyglucose positron emission tomography/computed tomography scan was performed after injection of 4. 9 mCi of flurodexoyglucose 2 mo following Yttrium 90 radioembolization. The post Yttrium 90 treatment positron emission tomography (PET) maximum intensity projection (MIP) coronal (A), attenuation corrected axial (B) and fused axial (C) PET images show complete resolution of all lesions with focal photopenia in the right hepatic lobe (white arrowheads). Incidentally, there is chemotherapy induced diffuse skeletal uptake and a small urinary bladder diverticulum (purple straight arrow A). The pre-therapy Positron emission tomography images are provided for comparison. Coronal MIP image (D) axial attenuation correction (E), and fused axial (F). Pretreatment PET images show multiple flurodexoyglucose avid right lobe hepatic (white arrows) and peritoneal (black arrows) lesions. PET: Positron emission tomography; MIP: Maximum intensity projection.